Spero Therapeutics, Inc. (SPRO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 15.86M | -8.35M | 17.42M | -17.69M | -4M | -23.4M | 12.76M | -18.74M | 5.94M | -17.49M | 15.91M | -18.56M | -12.85M | 44.48M | -957K | -23.03M | -28.22M | -27.35M | -4.95M | -16.57M |
| Operating CF Margin % | 6148.84% | -21.06% | 571.59% | -149.92% | -68.13% | -155.55% | 94.76% | -183.82% | 141.25% | -23.79% | 62.48% | -683.51% | -621.22% | 95.96% | -88.45% | -2570.65% | -11426.32% | -996.68% | -699.43% | -786.66% |
| Operating CF Growth % | 496.4% | 64.31% | 36.5% | 5.61% | -167.4% | -33.77% | -19.81% | -0.97% | 146.2% | -139.33% | 1763.01% | 19.4% | 54.46% | 262.65% | 80.67% | -39.03% | -82.33% | -66.94% | 76.71% | 33.46% |
| Net Income | -7.2M | 31.52M | -7.38M | -1.7M | -13.87M | -20.89M | -17.15M | -17.86M | -12.67M | 51.19M | -3.21M | -11.91M | -13.27M | 26.77M | -11.68M | -28.68M | -32.83M | -29.24M | -22.52M | -18.57M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 0 | 38K | 108K | 108K | 113K | 129K | 257K | 291K | 189K | 191K | 148K | 148K |
| Stock-Based Compensation | 0 | 1.01M | 1.05M | 714K | 1.56M | 1.5M | 2.15M | 2.11M | 2.02M | 2M | 1.91M | 1.86M | 2.17M | 2.5M | 2.11M | 0 | 3.2M | 2.93M | 2.33M | 2.16M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -154K | 0 | 89K |
| Other Non-Cash Items | 1.34M | 214K | 870K | 278K | 273K | 268K | 263K | 258K | 254K | 249K | 5.55M | 240K | 236K | 93K | 890K | 4.03M | 2.9M | 1.76M | 308K | 193K |
| Working Capital Changes | 21.73M | -41.09M | 22.89M | -16.98M | 8.04M | -4.28M | 27.49M | -3.25M | 16.33M | -70.97M | 11.55M | -8.86M | -2.11M | 14.99M | 7.46M | 1.33M | -1.69M | -2.83M | 14.78M | -588K |
| Change in Receivables | 25.34M | 1.56M | 869K | -1.79M | 2.42M | -389K | 2.04M | 283K | -3.47M | 1.44M | -901K | -223K | -781K | -131K | 624K | 393K | 0 | 0 | -394K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 131K | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -476K | -702K | 615K | -985K | -5.54M | 1.22M | 3.39M | -370K | 1.69M | 275K | -207K | 727K | -34K | -1.97M | 871K | -3.07M | 3.68M | -2.06M | 1.53M | -2.21M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.94M | -129K | 50M | -16.06M | -23.27M | 17.02M | 10.92M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -129K | 0 | 0 | 0 | 39K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.28% | - | - | - | 1.42% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 258K | -129K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 220K | 0 | 0 | 14.18M | 6.13M | -53.68M | 3.81M | 50.35M | 29.22M | 168K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -54.48M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 220K | 0 | 0 | 14.18M | 6.13M | 808K | 3.63M | 2.47M | 28.64M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | 0 | 188K | 47.88M | 583K | 168K |
| Net Change in Cash | 15.86M | -8.35M | 17.42M | -17.69M | -4M | -23.4M | 12.76M | -18.74M | 5.94M | -17.49M | 16.14M | -18.56M | -12.85M | 58.66M | 5.04M | -26.71M | -40.47M | -275K | 41.3M | -5.48M |
| Free Cash Flow | 15.86M | -8.35M | 17.42M | -17.69M | -4M | -23.4M | 12.76M | -18.74M | 5.94M | -17.49M | 15.91M | -18.56M | -12.85M | 44.35M | -957K | -23.03M | -28.22M | -27.31M | -4.95M | -16.57M |
| FCF Margin % | 6148.84% | -21.06% | 571.59% | -149.92% | -68.13% | -155.55% | 94.76% | -183.82% | 141.25% | -23.79% | 62.48% | -683.51% | -621.22% | 95.68% | -88.45% | -2570.65% | -11426.32% | -995.26% | -699.43% | -786.66% |
| FCF Growth % | 496.4% | 64.31% | 36.5% | 5.61% | -167.4% | -33.77% | -19.81% | -0.97% | 146.2% | -139.44% | 1763.01% | 19.4% | 54.46% | 262.41% | 80.67% | -39.03% | -82.33% | -66.58% | 76.77% | 33.5% |
| FCF per Share | 0.28 | -0.14 | 0.31 | -0.32 | -0.07 | -0.43 | 0.24 | -0.35 | 0.11 | -0.33 | 0.30 | -0.35 | -0.24 | 0.91 | -0.03 | -0.70 | -0.87 | -0.85 | -0.15 | -0.56 |
| FCF Conversion (FCF/Net Income) | -2.20x | -0.26x | -2.36x | 10.41x | 0.29x | 1.12x | -0.74x | 1.05x | -0.47x | -0.34x | -4.97x | 1.56x | 0.97x | 1.66x | 0.08x | 0.80x | 0.86x | 0.94x | 0.22x | 0.89x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |